Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11407727 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Patent 11407727 was granted and assigned to ADT Pharmaceuticals, LLC on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

ADT Pharmaceuticals, LLC

Current Assignee

ADT Pharmaceuticals, LLC

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Adam B. Keeton0

Xi Chen0

Michael R. Boyd0

Gary A. Piazza0

Date of Patent

August 9, 2022

Patent Application Number

16834267

Date Filed

March 30, 2020

Patent Citations

US Patent 10975054 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

US Patent 10526307 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

US Patent 11198679 Method of treating or preventing Ras-mediated diseases

US Patent 11186596 Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

US Patent 11130744 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

0

US Patent 11104658 Method of treating or preventing Ras-mediated diseases

US Patent 10981886 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

0

Patent Citations Received

US Patent 11680073 Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

0

Patent Primary Examiner

Amanda L. Aguirre

CPC Code

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11407727 Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool